MedDRA

65
The 2 nd Clinical Data Management Training AE/SAE Reporting and Coding Yu Zhang Roche

Transcript of MedDRA

Page 1: MedDRA

The 2nd Clinical Data Management Training

AE/SAE Reporting and Coding

Yu ZhangRoche

Page 2: MedDRA

AE/SAE reporting1

Coding2

Page 3: MedDRA

The 2nd Clinical Data Management Training

AE/SAE Reporting

Page 4: MedDRA

What is AE?

An AE (Adverse Events) is any unfavorable and

unintended medical occurrence/sign (including an

abnormal laboratory finding), symptom or disease in a

patient or clinical investigation subject administered a

pharmaceutical product and which does not necessarily have a causal relationship with this treatment.

Page 5: MedDRA

What is AE?(Cont.)

Occurrence/sign, symptom or disease

Administered a pharmaceutical product

No need causal relationship

Page 6: MedDRA

ADR (Adverse Drug Reaction )

All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions.

Page 7: MedDRA

Why collect AE?

Patient

Regulatory

Pharama ??

Page 8: MedDRA

vAE= Bad?

Page 9: MedDRA

AE collection form (example)

Name of AEOnset dateIntensity (Grade)Relationship with study medicationStudy medication adjustmentWhether or not a SAEOutcomeResolve dateTreatment for AEComments

Page 10: MedDRA
Page 11: MedDRA
Page 12: MedDRA

AE Term

Diagnosis

Symptom (location)

Sign (location)

One Events one AE

Check Writing

Do not use abbreviation

Page 13: MedDRA

Grade of AE

National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0 (CTCAE)

Page 14: MedDRA

Relationship with AE

If there is a reasonable suspected causal relationship to the study medication, i.e. there are facts (evidence) or arguments to suggest a causal relationship, drug-event relationship should be assessed as Yes.

Page 15: MedDRA

Relationship with AE

Yes criteria :

Reasonable temporal association with drug administration

Known response pattern to suspected drug

Disappears or decreases on cessation or reduction in dose

Reappears on rechallenge

Page 16: MedDRA

Relationship with AE

No criteria :

It does not follow a known pattern of response to the suspected drug.

It does not reappear or worsen when the drug is re-administered.

It does not follow a reasonable temporal sequence from administration of the drug.

Page 17: MedDRA

Relationship options

Unrelated

Remote

Possible

Probable

Page 18: MedDRA

Study medication adjustment

None

Adjusted/Interrupted

Discontinued

Page 19: MedDRA

Outcome and resolve date

Resolved (should record resolve date)

Unresolved

Death

Page 20: MedDRA

Exercise

一个病人在 2008 年 10 月 1 日注射研究用药过程中,出现了头疼的症状。医生觉得症状比较严重,是三级的不良事件,判断此次病人出现头疼与研究用药高度相关。于是医生中断了病人的注射,同时给病人服用了 A药以治疗头疼。持续服用 A 药后,头疼症状于 2008 年 10 月 3 日消失。

Page 21: MedDRA

SAE?

Criteria: Fatal (results in death) Life-Threatening Hospitalization or prolong hospitalization Anomaly/birth defect Disability/incapacity

is medically significant or requires intervention to prevent one or other of the outcomes listed above

Page 22: MedDRA

SAE reporting

Report to the sponsor

1 working day

Use SAE reporting form

Report to SFDA

Also Record in CRF

Microsoft Word Document

Page 23: MedDRA

SAE reporting to sponsor

Essential elements:

1) Protocol number

2) Patient Identifier: (patient ID, initial, birthday, gender)

3) Event term

4) Onset date

5) Drug name

6) Possible causes of event

7) Event seriousness

Page 24: MedDRA

The 2nd Clinical Data Management Training

AE/SAE Analysis

Page 25: MedDRA

AE/SAE analysis

Summary of AE by groupSummary of AE by Organ System by groupSummary of grade 3/4 AE by Organ System by groupSummary of related AE by Organ System by groupSummary of SAE by groupSAE listingTreatment for AE

P-value is not used for safety analysis

Page 26: MedDRA
Page 27: MedDRA
Page 28: MedDRA

The 2nd Clinical Data Management Training

SAE reconciliation

Page 29: MedDRA

Purpose of SAE reconciliation

Compare SAE for one study in Clinical database with SAE in Safety database to ensure the quality of SAE data.

DM will combine two SAE tables from different database into a SAE reconciliation report and send to scientist to review.

Page 30: MedDRA

SAE reconciliation process

Generate SAE reconciliation report

(Include patient ID, site number, birthday, SAE verbatim term, SAE prefer term, Onset date, relationship with study medication)

Review SAE reconciliation report

Resolve the discrepancy

Page 31: MedDRA

SAE reconciliation

Number of SAE (study/patient)Prefer termRelation with study medicationStart date

Page 32: MedDRA

The 2nd Clinical Data Management Training

Coding Overview

Page 33: MedDRA

Why?

To facilitate the aggregation of verbatim reports into medically meaningful groupings so that they can be reviewed, analysed and communicated to the regulatory authorities.

To ensure the accurate, unbiased & consistent classification of CRF verbatim terms as reported by the investigators

Page 34: MedDRA

Why Do Medical and Drug Terms Need to Be Classified?

Investigators report the same medical and treatment terms (called verbatim terms) in many different ways on the CRF. In order to compare the frequency of adverse events in drug treatment versus non treatment groups the terms need to be classified into standardized terminology.

Page 35: MedDRA

What?

AE term

Treatment Name

Page 36: MedDRA

How?

Medical events –

MedDRA (Medical Dictionary for Regulatory Activities)

Treatments and procedures –

INN (International Non-proprietary Name) WhoDrug (WHO Drug Dictionary)

Terms that match a dictionary term are classified automatically

Page 37: MedDRA

When are terms manually classified?

Terms that do not find an exact match among the terms in the dictionaries become discrepancies

Discrepancies for this terms will need Thesaurus review and coding

Page 38: MedDRA

Coding Discrepancy

Pain

Nausea & Vomiting

Headche

DIC

Hemoglobin

Page 39: MedDRA

Classification Process(AE term)

Data entered

Does the reported term match either a standard dictionary term or a previously linked verbatim

term

Term is automatically

classified

Edit made to the CRF/Database

Thesaurus discrepancy created

Can the term be classified appropriately by the Thesaurus

Specialist?

Term is sent to data management or site for

clarification

Term is manually classified

Let’s look at DM role

Term linked with PT and SCT

Page 40: MedDRA

The 2nd Clinical Data Management Training

MedDRA Dictionary

Page 41: MedDRA

Outline of this Session

History of MedDRA

MedDRA Scope & Structure

Current status of MedDRA

Page 42: MedDRA

MEDDRA

MedDRa

MEdDRA

MeddraMedDRA

MedrRA

Page 43: MedDRA

History of MedDRA

1989: UK Medicines Control Agency (MCA) 1989: UK Medicines Control Agency (MCA) identifies need for a single medical terminology identifies need for a single medical terminology for drug regulation to support its new computer for drug regulation to support its new computer databasesdatabases

1993: European Community identifies identical 1993: European Community identifies identical need to support its drug regulatory system. need to support its drug regulatory system. Wider applicability of MCA medical terminology Wider applicability of MCA medical terminology is assessedis assessed

Page 44: MedDRA

History of MedDRA (cont.)

1994: Working Party reviews and amends MCA 1994: Working Party reviews and amends MCA terminology, now called MEDDRA (Medical terminology, now called MEDDRA (Medical Dictionary for Drug Regulatory Affairs). ICH Dictionary for Drug Regulatory Affairs). ICH adopts MEDDRAadopts MEDDRA

1996: MedDRA 1.5 international Beta test 1996: MedDRA 1.5 international Beta test version releasedversion released

Page 45: MedDRA

History of MedDRA (cont.)

1997: ICH agrees the ‘implementation version’ 1997: ICH agrees the ‘implementation version’

(v2.0) and adopts new name: the Medical (v2.0) and adopts new name: the Medical

Dictionary for Regulatory Activities (MedDRA). Dictionary for Regulatory Activities (MedDRA).

Terms in MedDRA derive from WHO-ART, Terms in MedDRA derive from WHO-ART,

COSTART, HARTS, ICD-9, ICD 9-CMCOSTART, HARTS, ICD-9, ICD 9-CM

1998: Maintenance and Support Services

Organization (MSSO) is selected for 5 years by

ICH

Page 46: MedDRA

Early 1999: Services and distribution begin (with

v2.0)Each MedDRA term receives an unique 8-digit

numeric code to facilitate electronic transmission. This is sequential without inherent meaning

History of MedDRA (cont.)

Page 47: MedDRA

Scope of MedDRA

Patient demographic terms

Drug product terms

Device failure terms

Clinical trial study design terms

IncludedIncludedDiseases

Diagnoses

Signs & Symptoms

Therapeutic indications

Investigation names & qualitative results

Medical & surgical procedures

Medical and social history

ExcludedExcluded Population-led qualifiers

Numerical test results

Severity descriptors

Diagnostic products

Equipment and device terms

Page 48: MedDRA

MedDRA Structure

5 LevelsSOC: System Organ Class

HLGT: High Level Group Term

• HLT: High Level Term

– PT: Preferred Term

» LLT: Lowest Level Term

Page 49: MedDRA
Page 50: MedDRA

Basic Structure Example

SOC = Psychiatric disorders

HLGT = Dissociative disorders

HLT = Dissociative states

PT = Dissociative identity disorders

LLT = Multiple personality disorders

Page 51: MedDRA

Terminology

Special Search Category (SSC)

System Organ Class (SOC)

High Level Group Term (HLGT)

High Level Term (HLT)

Preferred Term (PT)

Lowest Level Term (LLT)

Standardised MedDRA Query

(SMQ)

Page 52: MedDRA

Analysis & Reporting Terms

Special Search Category (SSC)

System Organ Class (SOC)

High Level Group Term (HLGT)

High Level Term (HLT)

Preferred Term (PT)

Standardised MedDRA Query

(SMQ)

Lowest Level Term (LLT)

Page 53: MedDRA

Query Terms

Special Search Category (SSC)

System Organ Class (SOC)

High Level Group Term (HLGT)

High Level Term (HLT)

Preferred Term (PT)

Standardised MedDRA Query

(SMQ)

Lowest Level Term (LLT)

Page 54: MedDRA

Coding Terms

Special Search Category (SSC)

System Organ Class (SOC)

High Level Group Term (HLGT)

High Level Term (HLT)

Preferred Term (PT)

Lowest Level Term (LLT)

Standardised MedDRA Query

(SMQ)

Page 55: MedDRA

The 26 MedDRA SOCs

Blood - Blood and lymphatic system disorders

Card - Cardiac disordersCong - Congenital, familial and genetic

disordersEar - Ear and labyrinth disordersEndo - Endocrine disordersEye - Eye disordersGastr - Gastrointestinal disordersGenrl - General disorders and

administration site conditionsHepat - Hepatobiliary disordersImmun - Immune system disordersInfec - Infections and infestationsInj&P - Injury, poisoning and procedural

complicationsInv - InvestigationsMetab - Metabolism and nutrition

disorders

Metab - Metabolism and nutrition disordersMusc - Musculoskeletal, connective tissue

and bone disordersNeopl - Neoplasms benign, malignant and

unspecified (incl cysts and polyps)Nerv - Nervous system disordersPreg - Pregnancy, puerperium and

perinatal conditionsPsych - Psychiatric disordersRenal - Renal and urinary disordersRepro - Reproductive system and breast

disordersResp - Respiratory, thoracic and

mediastinal disordersSkin - Skin & subcutaneous tissue disordersSocCi - Social circumstancesSurg - Surgical and medical proceduresVasc - Vascular disorders

Page 56: MedDRA

LLT to SOC

SOC - General disorders and administration site conditions

HLGT - General system disorders NEC

HLT - Asthenic conditions

PT - Fatigue

LLT -Tired out

Page 57: MedDRA

Multiaxiality

Terms can be represented in more than one hierarchical path

Terms with more than one SOC will be assigned a primary SOC

Allows different clinical retrievals for analysis and presentations

Generally, PTs are assigned to the prime manifestation site system or organ-based SOC Example:

PT “Cardiac failure”

Primary SOC “Cardiac disorders”

Page 58: MedDRA

Simple Multiaxial Mapping

SOCPsychiatric disorders

HLGTPsychiatric and behavioural symptoms NEC

HLT Psychiatric symptoms NEC

PTHyperventilation

LLT

HLT Breathing abnormalities

HLGTRespiratory disorders NEC

SOCRespiratory, thoracic and mediastinal disorders

Page 59: MedDRA

HLGTDiabetic complications

SOCEye disorders

SOCVascular disorders

HLGTRetina, choroid and vitreous haemorrhages and vascular

disorders

HLTRetinopathies NEC

HLTDiabetic complications ophthalmic

PTDiabetic retinopathy

HLGTVascular disorders NEC

SOCEndocrine disorders

SOCMetabolism and

nutrition disorders

HLTOcular vascular disorders NEC

Complex Multiaxial Mapping

Page 60: MedDRA
Page 61: MedDRA

Hierarchy (V9.0)

(13) Special Search Category

(26) System Organ Class

(332) High Level Group Term

(1,682) High Level Term

(17,320) Preferred Term

(63,817) Lowest Level Term

(2) Standardised MedDRA Query

Page 62: MedDRA

What is new in MedDRA?

New MedDRA versions are released in March and September each year.

The Current version of MedDRA is version 14.0.

Page 63: MedDRA

MedDRAwww.meddra.com

Page 64: MedDRA

Q & A ?

Page 65: MedDRA

Thanks for your attention